<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01634464</url>
  </required_header>
  <id_info>
    <org_study_id>P06-CTS-02341</org_study_id>
    <secondary_id>334602 Preobe Follow Up</secondary_id>
    <nct_id>NCT01634464</nct_id>
  </id_info>
  <brief_title>Role of Nutrition and Maternal Genetics on the Programming of Development of Fetal Adipose Tissue</brief_title>
  <acronym>PREOBE</acronym>
  <official_title>The Role of Nutrition and Maternal Genetics on the Programming of Development of Fetal Adipose Tissue. Search for Markers of the Obesity Risk in Early Stages of Life</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universidad de Granada</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Spanish-Andalusian Ministry of Economy, Innovation and Science</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Abbott</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Scottish Government NuGO EU Project</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Barcelona</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>ICTAN-CSIC - Madrid - Spain</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Ludwig-Maximilians - University of Munich</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Nottingham</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>University of Aberdeen</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Agencia Andaluza del Conocimiento</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Universidad de Granada</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      In the PREOBE projects it is aimed to obtain genetic and biochemical biomarkers for the
      programming of obesity in early stages of life. This can be achieved by studying pregnant
      women with normal weight, overweight, obesity and gestational diabetes, and by analyzing how
      these conditions could impact on fetal growth and development; the risk of obesity in the
      offspring during the first 3 years of life will be also assessed (genetic polymorphisms of
      the most recognized genes related to obesity; gene expression of placental biomarkers
      indicators of early programming, polyunsaturated fatty acids, immunological and
      pro-inflammatory markers, analysis of endogenous and exogenous lipid peroxidation, allergies
      &amp; neurodevelopmental assessment...). Moreover, the interaction of pathological maternal
      conditions with confounder factors that could have a role in the proposed outcomes will be
      also studied (maternal and child dietary intake, medical history and socioeconomic &amp;
      environmental factors).
    </textblock>
  </brief_summary>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2007</start_date>
  <completion_date type="Anticipated">June 2013</completion_date>
  <primary_completion_date type="Actual">October 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Long-term evidence of early human programming of obesity measured by nutritional biomarkers, and the offspring growth and development.</measure>
    <time_frame>Participants will be followed for the duration of the study, an expected average of 6 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term evidence of early human programming of obesity measured by genetic biomarkers, and the offspring growth and development.</measure>
    <time_frame>Participants will be followed for the duration of the study, an expected average of 6 years</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Long-term evidence of early human programming of obesity measured biochemical perinatal biomarkers, and the offspring growth and development.</measure>
    <time_frame>Participants will be followed for the duration of the study, an expected average of 6 years</time_frame>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">300</enrollment>
  <condition>Obesity</condition>
  <condition>Diabetes</condition>
  <arm_group>
    <arm_group_label>Control group</arm_group_label>
    <description>women with 18.5 &gt; BMI &lt; 25</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregnant women with overweight</arm_group_label>
    <description>BMI≥25 before the pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregnant women with obesity</arm_group_label>
    <description>BMI≥30 before the pregnancy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Pregnant women with gestational diabetes</arm_group_label>
    <description>Gestational diabetes</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Maternal blood and blood from the umbilical cord, serum, plasma, placental tissue, placental
      tissue treated with RNAlater, saliva, oral mucosa, urine, faeces, human milk
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        A total of 350 pregnant women aged between 18 and 42, with singleton pregnancies, were
        recruited at 12 weeks of pregnancy at the Clinical University Hospital 'San Cecilio' and
        &quot;Mother-Infant&quot; Hospital in the city of Granada, Spain
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  healthy pregnant women aged between 18 and 42

          -  singleton pregnancies

          -  pregnancy stage at recruitment: 12 weeks of pregnancy

        Exclusion Criteria:

          -  Women who wish to participate in the study should not simultaneously participate in
             other research studies.

          -  Must be completely enclosed in one of the study of the groups without any possibility
             to be simultaneously incorporated on more groups of the study

          -  Mothers which are receiving any drug treatment, folate more than the 3rd first months,
             or DHA +/- vitamin supplements during pregnancy.

          -  Mothers affected by any disease other than those referred to the inclusion criteria,
             such hypertension or pre-eclampsia, foetal IUGR, mother infection during pregnancy,
             hypothyroidism / hyperthyroidism, hepatic diseases, renal disease,…

          -  Mothers following an extravagant diet or vegan diet.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>42 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cristina Campoy, Professor, MD</last_name>
    <role>Study Director</role>
    <affiliation>Universidad de Granada</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Cristina Campoy, Professor, MD</last_name>
    <phone>0034 629308695</phone>
    <email>ccampoy@ugr.es</email>
  </overall_contact>
  <location>
    <facility>
      <name>Department of Pediatrics, School of Medicine, University of Granada</name>
      <address>
        <city>Granada</city>
        <zip>18012</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Cristina Campoy, Professor, MD</last_name>
      <phone>0034 629308695</phone>
      <email>ccampoy@ugr.es</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <link>
    <url>http://www.proyectopreobe.com</url>
    <description>Official website for the PREOBE Project</description>
  </link>
  <results_reference>
    <citation>Santacruz A, Collado MC, García-Valdés L, Segura MT, Martín-Lagos JA, Anjos T, Martí-Romero M, Lopez RM, Florido J, Campoy C, Sanz Y. Gut microbiota composition is associated with body weight, weight gain and biochemical parameters in pregnant women. Br J Nutr. 2010 Jul;104(1):83-92. doi: 10.1017/S0007114510000176. Epub 2010 Mar 8.</citation>
    <PMID>20205964</PMID>
  </results_reference>
  <results_reference>
    <citation>Campoy C, Martín-Bautista E, García-Valdés L, Florido J, Agil A, Lorente JA, Marcos A, López-Sabater MC, Miranda-León T, Sanz Y, Molina-Font JA; grupo PREOBE. [Study of maternal nutrition and genetic on the foetal adiposity programming (The PREOBE study)]. Nutr Hosp. 2008 Nov-Dec;23(6):584-90. Spanish.</citation>
    <PMID>19132267</PMID>
  </results_reference>
  <verification_date>July 2012</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 19, 2012</study_first_submitted>
  <study_first_submitted_qc>July 2, 2012</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 6, 2012</study_first_posted>
  <last_update_submitted>July 5, 2012</last_update_submitted>
  <last_update_submitted_qc>July 5, 2012</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 9, 2012</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Universidad de Granada</investigator_affiliation>
    <investigator_full_name>Cristina Campoy</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

